SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes.

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.

Virtual reality relaxation program can reduce pain intensity, with significant changes in brain functional connectivity patterns.

Enfortumab vedotin plus pembrolizumab is more effective than chemotherapy as first-line treatment for metastatic urothelial cancer, data suggest.

Converting from the long-acting ESA methoxy polyethylene glycol-epoetin-ß (MPG-EPO) to thrice weekly vadadustat is feasible for the hemodialysis population.

Adding pembrolizumab to docetaxel did not significantly improve outcomes in previously treated patients with mCRPC.

(HealthDay News) — Microplastic exposure may increase the risk for chronic diseases, according to a study presented at the annual meeting of the American College of Cardiology, held from March 29 to ...

(HealthDay News) — Despite increased participation in U.S. long-distance running races, cardiac arrest incidence remains stable, according to a study published online March 30 in the Journal of the ...

The FDA has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.

Physician-scored and patient-reported bowel toxicity higher with dose-escalated moderately hypofractionated radiotherapy.

Secondary rectal cancer tumors that develop years after prostate cancer radiation therapy appear to differ in distinct ways from primary rectal cancers.